OCC 2016:梅斯医学专访上海第九人民医院王长谦副院长——临床科研更应注重成果的转化

2016-05-27 MedSci MedSci原创

第十届东方心脏病学会议(The 10th Oriental Congress of Cardiology,OCC 2016)于5月26日在上海世博中心(浦东新区世博大道 1500 号) 召开。梅斯医学(MedSci)作为官方媒体受邀参加此次大会。 上海第九人民医院王长谦院长作为心血管疾病预防论坛的坛主,做了关于血管内皮细胞功能和血清标志物及其临床应用的文章,梅斯医学有幸采



第十届东方心脏病学会议(The 10th Oriental Congress of Cardiology,OCC 2016)于5月26日在上海世博中心(浦东新区世博大道 1500 号) 召开。梅斯医学(MedSci)作为官方媒体受邀参加此次大会。

在5月26日下午的继续教育论坛专场,上海第九人民医院副院长、心内科主任王长谦(同时也是本届东方会心血管疾病预防论坛的坛主)做了题为《血管内皮细胞功能和血清标志物及其临床应用》的精彩报告,在报告后,梅斯医学有幸对王院长就临床医生做科研及心血管疾病预防和东方会亮点等问题进行了采访。



梅斯医学:王院长您好,您今天的演讲中介绍了您的团队的临床研究成果——内皮微粒作为一种血清标志物对血管内皮功能监测是可行的,且该研究是您的团队的原创研究。作为一名集医教研为一体的心内科专家,您对临床的年轻医生的科研工作有哪些建议?

王长谦院长:医学的发展离不开科研成果的发现,好医生不一定会做科研,但是会做科研的医生一定是优秀的医生。上海交通大学附属第九人民医院是以医疗为主,同时具有教学和科研工作的医院,我们医院医教研并重。因为九院是交通大学的教学医院,因此九院的年轻医生基本都是硕士、博士毕业生。许多年轻的医生在还是研究生的培养阶段时,已经有了一定的科研工作基础。因此,如何在临床中进一步做好科研工作,如何成长为一名优秀的医生,是值得中国和整个医疗体制都应重视的问题。
 
在过去,我国的医疗大环境都是以发表的文章数量,或课题、自然基金的数量评价,但存在一个问题,这些课题和论文有多少转化为临床成果了?有多少真正用于临床?目前国家已经重视到这个问题了,因此年轻医生的科研工作要加强对临床科研成果的转化。
 
其次,年轻医生在工作中应该善于发现问题,善于思考,善于查阅文献,善于提出思路。围绕临床问题提出方法,围绕临床问题寻找解决办法。临床医生不是基础研究科学家,临床医生的优势在于有更广阔的病例资源,容易发现临床存在的问题,可以围绕临床进行科研工作。这是我对临床医生做科研的一些希望。

梅斯医学:我们都知道您一直是血管疾病预防论坛的坛主,因此请您介绍一些近几年来,我国在心血管疾病的预防方面的重要的学术研究?

王长谦院长:东方会心血管疾病预防论坛是2010年来才开设的。在2010年的时候,我们发现,美国冠心病的发病率已经出现了转折点,美国冠心病的发病率开始下降了,然而在我国,虽然冠心病的死亡率在下降,但发病率依然在上升。因此,葛均波院士提出设立心血管疾病预防论坛,由我和顾水明教授负责预防论坛的工作。通过这几届东方会心血管论坛的组织,我们发现,心血管疾病的预防,说起来简单,如危险因素的控制、生活方式的改变、健康生活方式的提倡、合理的用药等,但实施起来却是非常困难的。心血管疾病的预防工作不仅仅是高危人群的预防,它更涉及到整个社会人群的预防。这需要整个社会的参与,包括政府、媒体、教育等各个部门,不仅仅是医院和医生。虽然难度很大,但我们的预防也取得了一定的成绩。
 
在心血管的预防中,霍勇教授发现了中国人群的高血压特点——H型高血压。在国外,心肌梗死是心血管疾病发病的主要途径,而在中国则是缺血性脑卒中,造成这种差异的原因是我国心血管疾病发病人群通常伴有血浆同型半胱氨酸水平的升高。霍勇教授的研究还发现了,叶酸可预防脑卒中,这是十分了不起的研究。该研究虽然是脑卒中相关的研究,但是间接促进了我国心内科医生对我国心血管病的深入了解,促进了我国心血管疾病的预防工作。

 
梅斯医学:心血管疾病预防论坛明天才正式开始,请您提前跟我们透露一下今年心血管疾病预防论坛的亮点有哪些?

王长谦院长:每年的心血管疾病预防论坛都有独特的亮点之处。总结下来主要包括以下几个方面

1.热点数据:对近1年来在心血管预防领域的新理论和新观点、新研究进行介绍;
2.指南解读:对新提出的心血管疾病预防相关的指南进行解读;
3.学术争鸣:对有争议的研究进行解读和讨论;
4.基础教育及继续教育。

另外,每年的心血管论坛还都会有一个主题,去年的主题是心血管病预防药物与消化道损伤的探讨,我们请来了仁济医院消化病专家发表观点,从消化病专家的角度看阿司匹林、他汀、抗血小板药物对消化道的损伤。今年的主题是糖尿病与心血管疾病的预防。糖尿病是心血管疾病的并发症,糖尿病患者可能需要强化降压、强化调整政策,和更低的治疗目标值。但近年来的研究发现,强化降糖并不能带来明显的心血管获益,哪些降糖药物能带来更多的心血管获益呢?这是我们今年关注的亮点之处。

梅斯医学:

梅斯医学(MedSci)是中国领先的医生互联网平台,拥有超过120万注册医生用户,主要从事临床研究、医生继续教育和培训,以及智慧医疗服务,旨在推动和加速临床医生的职业成长,改善医疗质量。


扫描并识别上方二维码,即可下载梅斯医学APP,了解更多精彩内容!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1703214, encodeId=e4281e0321465, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Nov 02 14:26:00 CST 2016, time=2016-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1914887, encodeId=4bd4191488ef2, content=<a href='/topic/show?id=e823249e392' target=_blank style='color:#2F92EE;'>#人民医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24973, encryptionId=e823249e392, topicName=人民医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Sun Oct 02 08:26:00 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035102, encodeId=556a2035102d6, content=<a href='/topic/show?id=faa0683683b' target=_blank style='color:#2F92EE;'>#王长谦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68368, encryptionId=faa0683683b, topicName=王长谦)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Sat Jul 16 11:26:00 CST 2016, time=2016-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033416, encodeId=9407203341601, content=<a href='/topic/show?id=8e6532e9732' target=_blank style='color:#2F92EE;'>#副院长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32797, encryptionId=8e6532e9732, topicName=副院长)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sat Oct 01 15:26:00 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87500, encodeId=ff8c8e50092, content=这是搞科研的目的, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Mon May 30 07:02:00 CST 2016, time=2016-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276821, encodeId=617512e682186, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun May 29 05:26:00 CST 2016, time=2016-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353024, encodeId=1ed0135302451, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun May 29 05:26:00 CST 2016, time=2016-05-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1703214, encodeId=e4281e0321465, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Nov 02 14:26:00 CST 2016, time=2016-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1914887, encodeId=4bd4191488ef2, content=<a href='/topic/show?id=e823249e392' target=_blank style='color:#2F92EE;'>#人民医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24973, encryptionId=e823249e392, topicName=人民医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Sun Oct 02 08:26:00 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035102, encodeId=556a2035102d6, content=<a href='/topic/show?id=faa0683683b' target=_blank style='color:#2F92EE;'>#王长谦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68368, encryptionId=faa0683683b, topicName=王长谦)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Sat Jul 16 11:26:00 CST 2016, time=2016-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033416, encodeId=9407203341601, content=<a href='/topic/show?id=8e6532e9732' target=_blank style='color:#2F92EE;'>#副院长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32797, encryptionId=8e6532e9732, topicName=副院长)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sat Oct 01 15:26:00 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87500, encodeId=ff8c8e50092, content=这是搞科研的目的, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Mon May 30 07:02:00 CST 2016, time=2016-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276821, encodeId=617512e682186, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun May 29 05:26:00 CST 2016, time=2016-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353024, encodeId=1ed0135302451, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun May 29 05:26:00 CST 2016, time=2016-05-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1703214, encodeId=e4281e0321465, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Nov 02 14:26:00 CST 2016, time=2016-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1914887, encodeId=4bd4191488ef2, content=<a href='/topic/show?id=e823249e392' target=_blank style='color:#2F92EE;'>#人民医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24973, encryptionId=e823249e392, topicName=人民医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Sun Oct 02 08:26:00 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035102, encodeId=556a2035102d6, content=<a href='/topic/show?id=faa0683683b' target=_blank style='color:#2F92EE;'>#王长谦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68368, encryptionId=faa0683683b, topicName=王长谦)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Sat Jul 16 11:26:00 CST 2016, time=2016-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033416, encodeId=9407203341601, content=<a href='/topic/show?id=8e6532e9732' target=_blank style='color:#2F92EE;'>#副院长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32797, encryptionId=8e6532e9732, topicName=副院长)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sat Oct 01 15:26:00 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87500, encodeId=ff8c8e50092, content=这是搞科研的目的, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Mon May 30 07:02:00 CST 2016, time=2016-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276821, encodeId=617512e682186, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun May 29 05:26:00 CST 2016, time=2016-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353024, encodeId=1ed0135302451, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun May 29 05:26:00 CST 2016, time=2016-05-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1703214, encodeId=e4281e0321465, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Nov 02 14:26:00 CST 2016, time=2016-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1914887, encodeId=4bd4191488ef2, content=<a href='/topic/show?id=e823249e392' target=_blank style='color:#2F92EE;'>#人民医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24973, encryptionId=e823249e392, topicName=人民医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Sun Oct 02 08:26:00 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035102, encodeId=556a2035102d6, content=<a href='/topic/show?id=faa0683683b' target=_blank style='color:#2F92EE;'>#王长谦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68368, encryptionId=faa0683683b, topicName=王长谦)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Sat Jul 16 11:26:00 CST 2016, time=2016-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033416, encodeId=9407203341601, content=<a href='/topic/show?id=8e6532e9732' target=_blank style='color:#2F92EE;'>#副院长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32797, encryptionId=8e6532e9732, topicName=副院长)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sat Oct 01 15:26:00 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87500, encodeId=ff8c8e50092, content=这是搞科研的目的, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Mon May 30 07:02:00 CST 2016, time=2016-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276821, encodeId=617512e682186, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun May 29 05:26:00 CST 2016, time=2016-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353024, encodeId=1ed0135302451, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun May 29 05:26:00 CST 2016, time=2016-05-29, status=1, ipAttribution=)]
    2016-10-01 xugumin
  5. [GetPortalCommentsPageByObjectIdResponse(id=1703214, encodeId=e4281e0321465, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Nov 02 14:26:00 CST 2016, time=2016-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1914887, encodeId=4bd4191488ef2, content=<a href='/topic/show?id=e823249e392' target=_blank style='color:#2F92EE;'>#人民医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24973, encryptionId=e823249e392, topicName=人民医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Sun Oct 02 08:26:00 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035102, encodeId=556a2035102d6, content=<a href='/topic/show?id=faa0683683b' target=_blank style='color:#2F92EE;'>#王长谦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68368, encryptionId=faa0683683b, topicName=王长谦)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Sat Jul 16 11:26:00 CST 2016, time=2016-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033416, encodeId=9407203341601, content=<a href='/topic/show?id=8e6532e9732' target=_blank style='color:#2F92EE;'>#副院长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32797, encryptionId=8e6532e9732, topicName=副院长)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sat Oct 01 15:26:00 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87500, encodeId=ff8c8e50092, content=这是搞科研的目的, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Mon May 30 07:02:00 CST 2016, time=2016-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276821, encodeId=617512e682186, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun May 29 05:26:00 CST 2016, time=2016-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353024, encodeId=1ed0135302451, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun May 29 05:26:00 CST 2016, time=2016-05-29, status=1, ipAttribution=)]
    2016-05-30 老段

    这是搞科研的目的

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1703214, encodeId=e4281e0321465, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Nov 02 14:26:00 CST 2016, time=2016-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1914887, encodeId=4bd4191488ef2, content=<a href='/topic/show?id=e823249e392' target=_blank style='color:#2F92EE;'>#人民医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24973, encryptionId=e823249e392, topicName=人民医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Sun Oct 02 08:26:00 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035102, encodeId=556a2035102d6, content=<a href='/topic/show?id=faa0683683b' target=_blank style='color:#2F92EE;'>#王长谦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68368, encryptionId=faa0683683b, topicName=王长谦)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Sat Jul 16 11:26:00 CST 2016, time=2016-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033416, encodeId=9407203341601, content=<a href='/topic/show?id=8e6532e9732' target=_blank style='color:#2F92EE;'>#副院长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32797, encryptionId=8e6532e9732, topicName=副院长)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sat Oct 01 15:26:00 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87500, encodeId=ff8c8e50092, content=这是搞科研的目的, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Mon May 30 07:02:00 CST 2016, time=2016-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276821, encodeId=617512e682186, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun May 29 05:26:00 CST 2016, time=2016-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353024, encodeId=1ed0135302451, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun May 29 05:26:00 CST 2016, time=2016-05-29, status=1, ipAttribution=)]
    2016-05-29 一闲
  7. [GetPortalCommentsPageByObjectIdResponse(id=1703214, encodeId=e4281e0321465, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Nov 02 14:26:00 CST 2016, time=2016-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1914887, encodeId=4bd4191488ef2, content=<a href='/topic/show?id=e823249e392' target=_blank style='color:#2F92EE;'>#人民医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24973, encryptionId=e823249e392, topicName=人民医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Sun Oct 02 08:26:00 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035102, encodeId=556a2035102d6, content=<a href='/topic/show?id=faa0683683b' target=_blank style='color:#2F92EE;'>#王长谦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68368, encryptionId=faa0683683b, topicName=王长谦)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Sat Jul 16 11:26:00 CST 2016, time=2016-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033416, encodeId=9407203341601, content=<a href='/topic/show?id=8e6532e9732' target=_blank style='color:#2F92EE;'>#副院长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32797, encryptionId=8e6532e9732, topicName=副院长)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sat Oct 01 15:26:00 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87500, encodeId=ff8c8e50092, content=这是搞科研的目的, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Mon May 30 07:02:00 CST 2016, time=2016-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276821, encodeId=617512e682186, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun May 29 05:26:00 CST 2016, time=2016-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353024, encodeId=1ed0135302451, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun May 29 05:26:00 CST 2016, time=2016-05-29, status=1, ipAttribution=)]
    2016-05-29 zhaojie88

相关资讯

2015 CSC&OCC(第九届东方心脏病学会议)会议议程

中华医学会第17次心血管大会暨第九届东方心脏病学会议(CSC&OCC2015)将于2015年9月10-13日在上海世博中心隆重举行,最新详细日程新鲜出炉,欢迎各位医生及时查阅。 点击这里查看议程 欢迎各位医生莅临指导! 高血压论坛: 9月11日13:30-9月13日10:30 上海世博中心616厅 心力衰竭论坛: 9月11日13:30-9月12日18:00 上海世博中心618厅

OCC 2014:吴宗贵教授接受MedSci专访

第八届东方心脏病学会议(OCC 2014)将于5月28日- 31日在上海国际会议中心(上海浦东新区滨江大道2727号)召开。本届大会倡导“以人为本,整体医学”。OCC2014还增设东方新星奖评选,增设了心脏急症论坛。 MedSci现场采访OCC大会执行主席吴宗贵教授 。 MedSci:吴教授,您好!非常感谢您接受我们medsci的采访,吴教授您作为临床中西医结合心血管学科的带头人,可否请您

2015 CSC&OCC(第九届东方心脏病学会议)热点抢先看

中华医学会第十七次全国心血管大会暨第九届东方心脏病学会议(2015 CSC&OCC)在充分整合中华医学会心血管年会和东方心脏病学会议原有框架的基础上,经广泛征求意见,学术内容涵盖心血管疾病预防、高血压、动脉粥样硬化、冠心病介入、心律失常、心力衰竭、结构性心脏病、肺循环疾病、女性心脏健康、心血管病影像、血栓相关病等领域,将为国内外参会者奉上一场精彩的学术盛宴。 冠心病介入论

OCC 2016:第十届东方心脏病学会议日程抢先看!

第十届东方心脏病学会议(The  10th  Oriental Congress of Cardiology,OCC 2016)将于 2016 年 5 月 26-29 日在上海世博中心(浦东新区世博大道 1500 号) 召开。尊敬的各位专家,各位同道:  秉承“开拓、进取、求真、务实”的八字方针,传承“开放、合作、创新(Open、Cooperation、Creative)”的会

OCC 2016:开放、合作、创新——海阔鱼跃,踏入国际学术平台

2016年5月26日,由上海市医学会、上海市医学会心血管病分会联合主办的“第十届东方心脏病学会议(OCC 2016)”在黄浦江畔的上海世博中心盛大开幕。上午10点,第十届东方心脏病学会议新闻发布会在世博中心东方直播室召开。新闻发布会由第二军医大学附属长征医院梁春教授主持,出席本次新闻发布会的专家有:中华医学会心血管病学分会侯任主任委员、复旦大学附属中山医院葛均波院士,中华医学会心血管病分会常委

OCC 2014:杨天伦教授谈心血管用药的常见误区

在东方心脏病学会议(OCC2014)上,中南大学湘雅医院杨天伦教授介绍了心血管用药的常见误区。 常见误区一:药物选择不当 杨教授用一首朗朗上口的小诗介绍了心内科医生用药的常见误区:“百药满天飞,千药漫天舞,选药不慎重,效差诟病多”。对此他解释道,心血管用药包括口服和静脉用药,其中前者包括抗高血压药、抗血小板药、抗凝药、抗心绞痛药和降脂药等,后者包括营养心肌药、抗心律失常药、抗心功能不全药和周围